Page last updated: 2024-09-05

deferasirox and Obesity

deferasirox has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cha, KM; Cheng, K; Gunton, JE; Ho, KW; Kodsi, R; Langley, N; Laybutt, DR; Nazari, M; Stokes, RA; Swarbrick, MM; Wang, M1

Other Studies

1 other study(ies) available for deferasirox and Obesity

ArticleYear
Iron chelation increases beige fat differentiation and metabolic activity, preventing and treating obesity.
    Scientific reports, 2022, 01-14, Volume: 12, Issue:1

    Topics: Adipose Tissue, Beige; Animals; Cell Differentiation; Deferasirox; Diet, High-Fat; Glucose; Humans; Iron Chelating Agents; Lipid Metabolism; Mice; Obesity; Thermogenesis; Uncoupling Protein 1

2022